Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
IMUC
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors
Codexis, Inc. REDWOOD CITY, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the appointment of Rahul Singhvi, Sc.D., to…
ImmunoCellular Therapeutics: Notice of Proposed Settlement of Derivative Action
LOS ANGELES, Aug. 09, 2019 (GLOBE NEWSWIRE) -- ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (OTC: IMUC), today issued the following announcement. The following is being released pursuant to an Order of the Superior Court of Califor…
New Research Coverage Highlights K12, ImmunoCellular Therapeutics, The First of Long Island, Blue Bird, The Providence Service, and German American — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Sept. 05, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of K12 Inc (NYSE:LRN),…
Research Report Identifies Gastar Exploration, Monroe Capital, SandRidge Energy, ImmunoCellular Therapeutics, Inseego, and Digital Turbine with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, Aug. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Gastar Exploration In…
Analysis: Positioning to Benefit within DDR, Diamond Offshore Drilling, Energen, ImmunoCellular Therapeutics, Juniper Networks, and ServiceNow — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, May 08, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of DDR Corp. (NYSE:DDR),…
Consolidated Research: 2018 Summary Expectations for People's United Financial, American International Group, ImmunoCellular Therapeutics, W&T Offshore, ONEOK, and Avon Products — Fundamental Analysis, Key Performance Indications
NEW YORK, March 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of People's United Fina…
Market Trends Toward New Normal in ONEOK, ServiceNow, Mirati, ImmunoCellular, United Technologies, and USG – Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ONEOK, Inc. (NYSE:OKE…
IMPORTANT IMMUNOCELLULAR THERAPEUTICS, LTD. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against ImmunoCellular Therapeutics, Ltd.
NEW YORK and SAN DIEGO, May 12, 2017 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (Nasdaq:I…
IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
IRVINE, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (NYSE:IMUC). Investors who purchas…
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against ImmunoCellular Therapeutics, Ltd. (IMUC)
NEW YORK, May 04, 2017 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (Nasdaq:IMUC) in the United States Dist…
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 – IMUC
NEW YORK, May 02, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular T…